Cargando…

Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein

BACKGROUND: RNA-binding proteins (RBPs) have been found to participate in the development and progression of cancer. This present study aimed to construct a RBP-based prognostic prediction model for lung adenocarcinoma (LUAD). METHODS: RNA sequencing data and corresponding clinical information were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Longjun, Zhang, Rusi, Guo, Guangran, Wang, Gongming, Wen, Yingsheng, Lin, Yongbin, Zhang, Xuewen, Yu, Xiangyang, Huang, Zirui, Zhao, Dechang, Zhang, Lanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039651/ https://www.ncbi.nlm.nih.gov/pubmed/33850871 http://dx.doi.org/10.21037/atm-21-452

Ejemplares similares

Analysis of the tumor immune environment identifies an immune gene set–based prognostic signature in non-small cell lung cancer
por: Guo, Guangran, et al.
Publicado: (2022)

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
por: Yang, Longjun, et al.
Publicado: (2022)

The independent prognostic effect of marital status on non-small cell lung cancer patients: a population-based study
por: Zhao, Dechang, et al.
Publicado: (2023)

The Independent Prognostic Effect of Lymph Node Dissection on Patients With Stage IA NSCLC With Different T Stages
por: Zhao, Dechang, et al.
Publicado: (2021)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer
por: Wen, Yingsheng, et al.
Publicado: (2022)

Ten-year trends of the clinicopathological characteristics, surgical treatments and survival outcomes of operable lung cancer patients in monocenter: a retrospective cohort study
por: Zhao, Dechang, et al.
Publicado: (2023)

SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial‐mesenchymal transition (EMT) in lung adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study
por: Zhang, Rusi, et al.
Publicado: (2020)

Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer
por: Zhang, Rusi, et al.
Publicado: (2020)

Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21–30 mm
por: Yu, Xiangyang, et al.
Publicado: (2021)

Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma
por: Zhang, Rusi, et al.
Publicado: (2022)

Combining Plasma miRNAs and Computed Tomography Features to Differentiate the Nature of Pulmonary Nodules
por: Xi, Kexing, et al.
Publicado: (2019)

Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
por: Wang, Weidong, et al.
Publicado: (2020)

Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer: a population-based study
por: Zhang, Rusi, et al.
Publicado: (2020)

The value of preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma
por: Yu, Xiangyang, et al.
Publicado: (2018)

Impact of Different Types of Lymphadenectomy Combined With Different Extents of Tumor Resection on Survival Outcomes of Stage I Non-small-cell Lung Cancer: A Large-Cohort Real-World Study
por: Wang, Weidong, et al.
Publicado: (2019)

Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer
por: Chen, Yongqiang, et al.
Publicado: (2018)

First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience
por: Yu, Xiangyang, et al.
Publicado: (2018)

Prognosis and distribution of lymph nodes metastases in resectable primary pulmonary lymphoepithelioma‐like carcinoma: A large cohort from a single center
por: Yu, Xiangyang, et al.
Publicado: (2018)

A new method for accurately localizing and resecting pulmonary nodules
por: Wang, Gongming, et al.
Publicado: (2020)

Development and validation of web-based dynamic nomograms predictive of disease-free and overall survival in patients who underwent pneumonectomy for primary lung cancer
por: Yu, Xiangyang, et al.
Publicado: (2023)

Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p
por: Liu, Yi, et al.
Publicado: (2021)

A comparison of MASS-PCR and ARMS-PCR for the detection of lung cancer gene mutation
por: Cai, Ling, et al.
Publicado: (2019)

Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020)

STIP1 Regulates Proliferation and Migration of Lung Adenocarcinoma Through JAK2/STAT3 Signaling Pathway
por: Guo, Xiangjun, et al.
Publicado: (2019)

Correction for: Development and validation of a RNA binding protein-associated prognostic model for lung adenocarcinoma
por: Li, Wei, et al.
Publicado: (2021)

Evaluation of the significance of subcarinal lymph node dissection in stage IB non‑small cell lung cancer
por: Wang, Feng, et al.
Publicado: (2023)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Immune-Related RNA-Binding Protein-Based Signature With Predictive and Prognostic Implications in Patients With Lung Adenocarcinoma
por: Xu, Lei, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

A Model Shows Utility in Predicting Postoperative Recurrence and Distant Metastasis in Curatively Resected Esophageal Squamous Cell Cancer
por: Wang, Weidong, et al.
Publicado: (2019)

Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein
por: Meng, Liangliang, et al.
Publicado: (2020)

Identification and Validation of a Novel Six-lncRNA-Based Prognostic Model for Lung Adenocarcinoma
por: Yang, Lingge, et al.
Publicado: (2022)

Development and Validation of a Seven-Gene Signature for Predicting the Prognosis of Lung Adenocarcinoma
por: Zhang, Yingqing, et al.
Publicado: (2020)

Identification and Validation of a Ferroptosis-Related Long Non-coding RNA Signature for Predicting the Outcome of Lung Adenocarcinoma
por: Zheng, Zhiyuan, et al.
Publicado: (2021)

Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
por: Wang, Jixin, et al.
Publicado: (2021)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction
por: Li, Linfeng, et al.
Publicado: (2023)

Identification and Validation Prognostic Impact of MiRNA-30a-5p in Lung Adenocarcinoma
por: Jiang, Xiulin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_atncn7mr5kj71ki3d5ho0ul70h